Despite many studies on the significance of HNF4α as an important target in preventing and treating liver malignancies, further investigations are still required to understand the mechanism and the correlation between CLA and HNF4α in regulating and inhibiting EMT. The gene discussed is HNF4A; the disease is digestive system neoplasm.